#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 11

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Efficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cobolimab

Contact Research Centre

Osteosarcoma

Not recruiting

Registered drugNo placebo

Efficacy and Safety of Maintenance Cabozantinib Plus Best Supportive Care in Pediatric and AYA Patients with Unresectable Residual Osteosarcoma

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Cabozantinib

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

A study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Malignant melanoma stage IV+1

Not recruiting

Registered drugNo placebo

Study of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

A Study of Lifileucel with Cyclophosphamide, Fludarabine, and Aldesleukin for Adults with Previously Treated Advanced Melanoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Aldesleukin

Contact Research Centre

Avian influenza

Not recruiting

Registered drugNo placebo

Study of H5N8 influenza vaccine in adults previously vaccinated with H5N1/MF59 vaccine compared to those never vaccinated with H5 vaccine

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years · Healthy volunteers

Contact Research Centre

Adenocarcinoma gastric+3

Not recruiting

Registered drug

Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Registered drug

Study on the Effects of CAL101 for Patients with Idiopathic Pulmonary Fibrosis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:CAL101

Contact Research Centre

Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18+ with Lung or Kidney Transplants at Risk of RSV Infections, Compared to Healthy Adults 50+

Not recruiting

Registered drugNo placebo

Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18+ with Lung or Kidney Transplants at Risk of RSV Infections, Compared to Healthy Adults 50+

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Nilotinib

Contact Research Centre

Obesity

Not recruiting

Investigational

Study on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study of roginolisib, dostarlimab and docetaxel combination for patients with advanced non-small cell lung cancer who did not respond to previous immunotherapy and chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.